Select Currency

About “Jennifer A. Maynard”

  • Bio
  • Active grants
  • My notes


Professor Jennifer Maynard develops protein vaccines and therapeutics to address unmet medical needs in infectious diseases. This involves identifying or designing a candidate protein, as well as determining its mechanism of action at the molecular level, using in vitro and in vivo experiments. While this work relies heavily upon protein biochemistry skills, it also uses biotechnology, microbiology, immunology, and cellular biology skills.

She earned a B.A. in human biology from Stanford University, a Ph.D. in chemical engineering from UT Austin, and completed post-doctoral studies at Stanford. She has developed two separate antibody therapeutics to treat infectious diseases from initial engineering and biochemical characterization through animal studies, including non-human primates. Her students often pursue careers in the biotechnology and pharmaceutical industries directly after graduation.